NCT01614743View on ClinicalTrials.gov

A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Rosacea
Interventions
DRUG

IncobotulinumtoxinA

Experimental injection given at baseline and Week 16

DRUG

Bacteriostatic saline

Placebo at baseline, incobotulinumtoxinA at 16 weeks

Trial Locations (1)

60611

DeNova Research, Chicago

Sponsors

Lead Sponsor

DeNova Research
All Listed Sponsors
collaborator

Merz North America, Inc.

INDUSTRY

lead

DeNova Research

OTHER

NCT01614743 - A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea | Biotech Hunter | Biotech Hunter